Call for Abstract

6th European Biopharma Congress, will be organized around the theme “Novel Strategies and Advancements in Biopharmaceutics”

Euro Biopharmaceutics 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Euro Biopharmaceutics 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

A biopharmaceutical is likewise called as a Biological or Biologic pharmaceutical medicine thing manufactured from natural sources through extraction. The progression of a pharmaceutical medicine regularly takes a typical of 10 – 15 years. Such a lot of effort, time and money, it is particularly pressing that the right headways and materials are gotten in the examination, change and amassing of the pharmaceutical solutions, entire process consolidates pre-exposure, pre-clinical trials, exhibit dispatch to post advancing watching. The wellsprings of prescription things fuse peptides and proteins, including monoclonal antibodies and neutralizer pieces. From 2000 to 2006, biologics spoke to 33% of all New Active Substances that were pre moved, and are reflected to the present headway pipelines of the pharmaceutical business.

  • Track 1-1Sources of biopharmaceuticals
  • Track 1-2Biopharmaceuticals latest developments
  • Track 1-3Bioinformatics
  • Track 1-4Bioincs
  • Track 1-5Biogenetics

Biopharmaceutical Drug Designing and Development is an interdisciplinary research. Focusing upon solution arranging strategies, new prescriptions headways in engineered and natural research. An achievement of definition depends on upon how adequately it makes the medicine open at the site of movement, especially in oral designs. Strategies have consistently been used to extend breaking down rate of the medicine. Critical to improve dissolvability of drug by various ways like salt advancement, co-dissolvability.

  • Track 2-1Biomedical computational drug discovery
  • Track 2-2Biochemistry laboratory technique
  • Track 2-3Novel therapeutics of modern biotechnology

Products that are obtained from specific organs or tissues said to correspond with the unhealthy organs or tissues of the recipient. Proponents claim that the recipient's body automatically transports the injected cells to the target organs, where they supposedly strengthen them and regenerate their structure. The organs and glands used in cell treatment include brain, pituitary, thyroid, adrenals, thymus, liver, kidney, pancreas, spleen, heart, ovary, testis, and parotid. Several different types of cell or cell extract can be given simultaneously - some practitioners routinely give up to 20 or more at once.

  • Track 3-1Recommbinant r dna
  • Track 3-2Extracts from living organisms
  • Track 3-3macromolecular products

The development of biologics calls for overcoming lot many challenges. With initial steps of concepts of biologics, their considerations, essentials for early clinical developments it is very much needed that proper scientific and strategic approaches are taken for the successful development of follow-on-biologics. Moreover, the need for overcoming the challenges continues in the late clinical steps, drug safety factors and labelling requirements. Also it is much required now to develop a drug product in accordance to quality by design (QbD). This Euro Biopharma 2017 conference will look at the multiple facets of current challenges in biosimilar development. This conference will focus on multiple aspects of biosimilar product development to successfully deliver safe, potential and efficacious biologic products to the market.

  • Track 4-1Immunoassays
  • Track 4-2spectrometry
  • Track 4-3biosimilar research pipelines
  • Track 4-4liquid chromotography

Clinical Trials is a multidisciplinary program with broad participation with members from around the globe focused on learning about clinical research and its advances. This is your best opportunity to reach the largest assemblage of participants from Clinical Trials community that is from academia, clinical research entities, medical groups, related associations, societies and also from government agencies, pharmaceutical, biomedical and medical device industries. Clinical Trials  will discuss various disciplines involved in the pre-clinical research, conduct of clinical trials; it will educate health care researchers about design, operation, organizing, research computing, regulatory aspects and reporting of clinical trials. It promotes better understanding by the general public about the importance of clinical trials in prevention, diagnosis and treatment of disease.

  • Track 5-1Regulatory updates
  • Track 5-2Clinical design
  • Track 5-3latest updatesin clinical trails
  • Track 5-4upcoming challenges in clinical trails

Drug Delivery system attains greater global significance as Drug Delivery System plays a significant role in the future of pharmaceutical research Novel drug delivery system method by which a drug is delivered can have a significant effect on its efficacy. This includes topics like lipid Polymers to enhance drug delivery technology by providing controlled release of therapeutic agents in constant doses over long periods, cyclic dosage, and tunable release of both hydrophilic and hydrophobic drugs. The major part is to deliver an innovative speech on the latest Targeted drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others Drug 

  • Track 6-1Solubility enhancement
  • Track 6-2Challenges in drug development
  • Track 6-3Challenges in drug design
  • Track 6-4Drug elimination and clearance
Cell therapy as performed by alternative medicine practitioners is very different from the controlled research done by conventional stem cell medical researchers. Alternative practitioners refer to their form of cell therapy by several other different names including Immunotherapy, Allogenic Cell Therapy and fresh Neural Stem cell therapy. Proponents of cell therapy claim that it has been used successfully to rebuild damaged cartilage in joints, repair spinal cord injuries,strengthen a weakened immune system, treat autoimmune diseases such as AIDS, and help patients with neurological disorders such as Alzheimer’s disease, Parkinson's disease and epilepsy.
 
Gene therapy and cell therapy are overlapping fields of biomedical research with the goals of repairing the direct cause of genetic diseases in the DNA or cellular population, respectively. The development of suitable gene therapy treatments for many genetic diseases and some acquired diseases has encountered many challenges and uncovered new insights into gene interactions and regulation. Further development often involves uncovering basic scientific knowledge of the affected tissues, cells, and genes, as well as redesigning vectors, formulations, and regulatory cassettes for the genes.
  • Track 7-1Transplantaion
  • Track 7-2Treatment for several immunodeficiency disease
  • Track 7-3Gene interaction and regulation

The Bioavailability Bioequivalence Research Center aims to become a regional center of excellence for assuring the safety and efficacy of generic pharmaceutical products for human use. It plays a key role in the drug development period for both new drug products and their generic equivalents. These studies are also important in the post approval period in the presence of certain manufacturing changes. Information in the overall set of data that ensure the availability of safe and effective medicines to patients and practitioners can be discussed

  • Track 8-1Factors affecting bae
  • Track 8-2BABE studies
  • Track 8-3Assesssment of bioeqivalence
  • Track 8-4In vivo/In vitro studies
  • Track 8-5Latest Updates In BA/BE

Pharmaceutical Biotechnology is an increasingly important area of science and technology, and contributes to design and delivery of new therapeutic drugs, the development of diagnostic agents for medical tests, and the beginnings of gene therapy for correcting the medical symptoms of hereditary diseases. Pharmaceutical Biotechnology is pioneering in the UK, providing a detailed insight into the technologies that allow the development and production of biopharmaceuticals that could lead to cures for most major diseases.

  • Track 9-1biological drugs
  • Track 9-2Biowaivers
  • Track 9-3Protein interactions
  • Track 9-4Herbal drug interactions

Once a particular medicine is chosen, the principles of clinical pharmacokinetics are required to ensure the appropriate formulation of drug is chosen for an appropriate route of administration. On the basis of the patient’s drug handling parameters, which require an understanding of absorption, distribution, metabolism and excretion, the dosage regimen for the medicine in a particular patient can be developed. The pharmacist will then need to ensure that the appropriate regimen is prescribed to achieve optimal efficacy and minimal toxicity. Pharmacists then ensure that the appropriate monitoring is undertaken and that the patient receives the appropriate information to ensure compliance. Clinical pharmacokinetics  is thus a fundamental knowledge base that pharmacists require  to ensure effective practice of pharmaceutical care.

  • Track 10-1Drug disposition
  • Track 10-2Disposition curve
  • Track 10-3 Pharmaceutical research and development. 
  • Track 10-4 Safe and Effective use
  • Track 10-5 Mechanisms of action and toxicity.

Good Manufacturing Practices quality of drugs is essentially the responsibility of manufacturers. GMP Guidelines are means to assure this very quality of drugs. CGMP refers to the Current Good Manufacturing Practice regulations enforced by the US Food and Drug Administration (FDA). cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities. Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. GMP is actually good common sense quality management quality assurance GMP production and quality control.

  • Track 11-1Drug Safety of Biopharma products
  • Track 11-2Regulatory Aspects
  • Track 11-3Regulatory Affairs And IPR of Biopharma Products

The field of Pharmacovigilance is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. Euro Biopharma 2017  emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. With members from around the world focused on learning about Pharmacovigilance and its advances;

  • Track 12-1Adverse drug reactions
  • Track 12-2Drug administration
  • Track 12-3Safety measures of the drug

Disintegration has become an important and broadly used test receiving more accentuation worldwide from regulatory specialists amid the last 15 years. It is a critical quality control excessively l ,and a guide, making it impossible to formulation development .Dissolution testing measures change on stability, and is utilized to build up in-vitro in-vivo correlations for some products. The disintegration test has experienced changes and updates subsequently of the expanded regulatory interest and the pharm practical industry's examination of aspects of disintegration testing to additionally enhance and get it the technique.

  • Track 13-1Drug disposition
  • Track 13-2 Pharmaceutical research and development. 
  • Track 13-3 Safe and Effective use
  • Track 13-4 Mechanisms of action and toxicity.

Pharmaceutical analytic market research deals with the collection, analysis, and interpretation of details and information relating to the market environment of a given pharmaceutical product – in general of a medical drug. The primary objective of pharmaceutical market research is to gain as realistic and objective as possible an impression of the marketing opportunities of a given pharmaceutical product, thus enabling the identification of the chances and risks associated with its development potential as early on as possible.

  • Track 14-1Market Scope in Europe
  • Track 14-2Latest Updates In Biopharma Market